Establishment Labs Holdings (ESTA) Share-based Compensation Growth (3y) (2020 - 2026)
Establishment Labs Holdings (ESTA) Share-based Compensation Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 8.37% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -28.31% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 13.19% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 4.11% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -0.59% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 17.13% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 36.49% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 3.40% |
| 10 | Establishment Labs Holdings | 2.20 Bn | 2.13 Bn | 47.71 Mn | -3.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.67% |
| Mar 31, 2026 | -3.33% |
| Dec 31, 2025 | 40.58% |
| Sep 30, 2025 | -30.14% |
| Jun 30, 2025 | 43.05% |
| Mar 31, 2025 | -10.84% |
| Dec 31, 2024 | 10.73% |
| Sep 30, 2024 | 88.45% |
| Jun 30, 2024 | 28.30% |
| Mar 31, 2024 | -59.23% |
| Dec 31, 2023 | 40.74% |
| Sep 30, 2023 | -3.98% |
| Jun 30, 2023 | 689.06% |
| Mar 31, 2023 | 22.17% |
| Dec 31, 2022 | -26.83% |
| Sep 30, 2022 | 91.23% |
| Jun 30, 2022 | -43.17% |
| Mar 31, 2022 | 294.34% |
| Sep 30, 2021 | 26.12% |
| Jun 30, 2021 | -46.49% |